Dan Puckett, Chief Financial Officer at Shockwave Medical, Inc. (SWAV), sold 6,801 shares at $228.53 ($1.6M) on 2024-02-01, disclosed to the SEC on 2024-02-02.
Scheduled sale ($1.6M) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $228.53 | 1,090 | $249K | 15.9% |
| 2 | $228.53 | 1,090 | $249K | 15.9% |
| 3 | $229.24 | 613 | $141K | 9.0% |
| 4 | $229.24 | 613 | $141K | 9.0% |
| 5 | $230.74 | 1,692 | $390K | 25.0% |
| 6 | $230.74 | 1,692 |
| $390K |
| 25.0% |
| 7 | $231.16 | 11 | $3K | 0.2% |
| Total | $229.76 avg | 6,801 | $1.6M | 100% |
| Filing → |
| SWAV | SELL | 2023-05-12 | $1.2M | — | Filing → |
| SWAV | SELL | 2023-04-19 | $530K | — | Filing → |
| SWAV | SELL | 2023-03-22 | $221K | — | Filing → |